Centessa Pharmaceuticals CNTA Q1 2026 Earnings EPS Miss Amid PreRevenue Phase Stock Slips Slightly PNFP Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Reaction SB Q4 2025 Earnings Slight EPS Miss Amid Dry Bulk Market Volatility STEX Q1 2026 Earnings Significant EPS Miss Amid Surprising Stock Rally Nuwellis Q1 2026 Earnings Significant EPS Miss Despite Stock Gain BTCT Q4 2024 Earnings Surprise Profitability Despite Revenue Absence